⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 17, 2019Expert Opinion on Drug DiscoveryOpen Access

Can we further optimize statin therapy to increase tolerability?

View Full Paper

Ask AI

Bookmark

Share

Abstract

KEYWORDS: StatinmyalgiaLILRB5immune-mediated necrotizing myopathyPCSK9bempedoic acidnocebo effectdrucebo effect

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ruscica et al. (2019) studied this question.

synapsesocial.com/papers/6a17c1fc8008e5848e6f03d1 https://doi.org/10.1080/17460441.2019.1615436

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

1Statins for the primary prevention of cardiovascular diseaseRCT · 2013 · 1,834 citations
2Metformin increases the PGC-1α protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivoOriginal Research · 2006 · 207 citations